German acromegaly patients interim results from the International Observational Acromegaly Study on impact of sandostatin LAR OASIS

被引：0
|
作者：
Petersenn, S.
Etzrodt, H.
Sievers, C.
Droste, M.
Wallaschofski, H.
Decroix, L.
Stalla, G. K.
机构：
[1] Univ Klinikum Essen, Essen, Germany
[2] Max Planck Inst Psychiat, Dept Neuroendocrinol, D-80804 Munich, Germany
[3] Univ Klinikum Greifswald, Greifswald, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2007年 / 115卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P7
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [21] Time to first remission and survival in patients with acromegaly: Evidence from the UK Acromegaly Register Study (UKAR)
    Deshmukh, Harshal
    Ssemmondo, Emmanuel
    Adeleke, Kazeem
    Mongolu, Shiva
    Aye, Mo
    Orme, Steve
    Flanagan, Daniel
    Abraham, Prakash
    Higham, Claire
    Sathyapalan, Thozhukat
    CLINICAL ENDOCRINOLOGY, 2024, 101 (03) : 274 - 281
  • [22] Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study
    Sulu, Cem
    Bektas, Ayyuce Begum
    Guzel, Suleyman Sami
    Tay, Kubilay
    Sahin, Serdar
    Durcan, Emre
    Ozkaya, Hande Mefkure
    Kadioglu, Pinar
    GROWTH HORMONE & IGF RESEARCH, 2022, 66
  • [23] Patients lost to follow-up in acromegaly: results of the ACROSPECT study
    Delemer, B.
    Chanson, Ph
    Foubert, L.
    Borson-Chazot, F.
    Chabre, O.
    Tabarin, A.
    Weryha, G.
    Cortet-Rudelli, C.
    Raingeard, I.
    Reznik, Y.
    Reines, C.
    Bisot-Locard, S.
    Castinetti, F.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (05) : 791 - 797
  • [24] Somatuline Depot-Treated Patients with Acromegaly in the United States: Preliminary Results from the Somatuline® Depot [lanreotide] Injection for Acromegaly (SODA) Study.
    Gordon, M.
    Molitch, M.
    Grua, J.
    Rios, V. M., Jr.
    Chang, S.
    Blethen, S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [25] PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY
    Kreitschmann-Andermahr, Ilonka
    Buchfelder, Michael
    Kleist, Bernadette
    Kohlmann, Johannes
    Menzel, Christa
    Buslei, Rolf
    Koltowska-Hggstroem, Maria
    Strasburger, Christian
    Siegel, Sonja
    ENDOCRINE PRACTICE, 2017, 23 (01) : 79 - 88
  • [26] Impact of Somatostatin Analogs Versus Surgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study
    Colao, Annamaria
    Auriemma, Renata S.
    Galdiero, Mariano
    Cappabianca, Paolo
    Cavallo, Luigi M.
    Esposito, Felice
    Grasso, Ludovica F. S.
    Lombardi, Gaetano
    Pivonello, Rosario
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02): : 528 - 537
  • [27] Hypogonadism in patients with acromegaly: data from the multicentre acromegaly registry pilot study (vol 54, pg 183, 2001)
    Katznelson, L
    Kleinberg, D
    Vance, ML
    Stavrou, S
    Pulaski, KJ
    Schoenfeld, DA
    Hayden, DL
    Wright, ME
    Klibanski, A
    CLINICAL ENDOCRINOLOGY, 2001, 55 (05) : 699 - 699
  • [28] Posture and balance control in patients with acromegaly: Results of a cross-sectional study
    Lopes, Agnaldo Jose
    Guedes da Silva, Debora Pedroza
    Kasuki, Leandro
    Gadelha, Monica Roberto
    Camilo, Gustavo Bittencourt
    Guimaraes, Fernando Silva
    GAIT & POSTURE, 2014, 40 (01) : 154 - 159
  • [29] Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
    Schreiber, I.
    Buchfelder, M.
    Droste, M.
    Forssmann, K.
    Mann, K.
    Saller, B.
    Strasburger, C. J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (01) : 75 - 82
  • [30] Diagnosis of Acromegaly: Results from 100 Patients Followed in a Single Center.
    Aydin, Kadriye
    Cinar, Nese Unal
    Dagdelen, Selcuk
    Erbas, Tomris
    ENDOCRINE REVIEWS, 2010, 31 (03)
12345